Recombinant MED12 anticorps (AA 2127-2177)
Aperçu rapide pour Recombinant MED12 anticorps (AA 2127-2177) (ABIN7453977)
Antigène
Voir toutes MED12 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 2127-2177
-
Fonction
- Rabbit anti-MED12 Recombinant Monoclonal Antibody [BLR084G] - BSA-Free
-
Purification
- Purified
-
Immunogène
- between AA 2127 and 2177 (C-term)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1000 μg/mL
-
Buffer
- Borate Buffered Saline (BBS) pH 8.2 with 0.09 % Sodium Azide, BSA-Free
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- 2 - 8 °C
-
Date de péremption
- 12 months
-
-
- MED12 (Mediator Complex Subunit 12 (MED12))
-
Autre désignation
- MED12
-
Sujet
- MED12 is a component of the multisubunit mediator complex that functions as an interface between gene-specific transcription factors and the RNA Pol II/general transcription factor machinery. The mediator complex was first identified as a coactivator of the thyroid hormone receptor and has since been observed to function as a coactivator of a variety of transcription factors. In this context, MED12 interaction with beta-catenin has been shown to be required for Wnt-signaling dependent transcription.
-
ID gène
- 9968
-
UniProt
- Q93074
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Nuclear Hormone Receptor Binding, Stem Cell Maintenance, Chromatin Binding, Regulation of Lipid Metabolism by PPARalpha, Tube Formation
Antigène
-